Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 102 (1), 32-38
- https://doi.org/10.1016/s0091-6749(98)70052-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school childrenThorax, 1997
- Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1)European Respiratory Journal, 1996
- Early childhood respiratory symptoms and the subsequent diagnosis of asthmaJournal of Allergy and Clinical Immunology, 1996
- A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of AsthmaJournal of Asthma, 1996
- Asthma and Wheezing in the First Six Years of LifeNew England Journal of Medicine, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- A placebo controlled trial of fluticasone propionate in asthmatic childrenEuropean Journal of Pediatrics, 1993
- Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthmaThe Lancet, 1992
- A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthmaJournal of Allergy and Clinical Immunology, 1977
- AEROSOL BECLOMETHASONE DIPROPIONATE: A DOSE-RESPONSE STUDY IN CHRONIC BRONCHIAL ASTHMAThe Lancet, 1973